Adjusting the dose of low molecular weight heparins in renally impaired and obese patients.
Spinler
Sarah
S
University of the Sciences in Philadelphia, USA.
D000925:Anticoagulants / Q000008:administration & dosage* / Q000493:pharmacokinetics; D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality; D015897:Comorbidity; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D017984:Enoxaparin / Q000008:administration & dosage / Q000493:pharmacokinetics; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D007674:Kidney Diseases / Q000453:epidemiology / Q000378:metabolism* / Q000628:therapy; D008657:Metabolic Clearance Rate; D009765:Obesity / Q000453:epidemiology / Q000378:metabolism*; D006435:Renal Dialysis; D012189:Retrospective Studies
D000925:Anticoagulants; D015415:Biomarkers; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight; D003404:Creatinine